Literature DB >> 29331040

Jun, Gal, Cd74, and C1qb as potential indicator for neuropathic pain.

Ji-An Yang1, Jun-Min He1, Jing-Min Lu2, Li-Jian Jie3.   

Abstract

Neuropathic pain is a kind of pain caused by primary or secondary impairment or dysfunction of peripheral or central nervous system. Patients with neuropathic pain were often with poor clinical outcome. We screened the differentially expressed genes between sciatic nerve injury and dorsal root ganglion gene in the sham operation model. Microarray and the spared nerve injury module were used to explore the molecular mechanism of neuropathic pain by injuries and the differentially expressed genes (DEGs) were identified out. Besides, the bioinformatics methods were used to figure out the signaling pathways and expression regulation pattern these DEGs were enriched in, which may provide a basis for the molecular research and medicine target of therapy. Besides, protein-protein interaction network analysis was performed on these selected intersection genes. A total of 40 DEGs were screened out and only pctp gene was down-regulated, the left 39 genes were all up-regulated. Then, GO and KEGG enrichment analysis were performed on these intersection genes by DAVID software. Furthermore, protein-protein interaction network analysis was used to analyze the critical genes of neuropathic pain. Finally, four genes, that is, Jun, Gal, Cd74, and C1qb were identified to have strong interactions with other genes, which may function as the prognostic and predictive genes of neuropathic pain caused by peripheral injuries. Our results suggested that four differentially expressed genes, Jun, Gal, Cd74, and C1qb, had the potential to serve as prognostic or predictive markers for neuropathic pain, suggesting a potential application in the improvement of prognostic tools and treatments.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  differentially expressed genes; functional enrichment analysis; neuropathic pain; protein-protein interaction network

Mesh:

Substances:

Year:  2018        PMID: 29331040     DOI: 10.1002/jcb.26673

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Microarray analysis of potential biomarkers of brachial plexus avulsion caused neuropathic pain in male rat.

Authors:  Le Wang; Jie Lao
Journal:  BMC Neurosci       Date:  2022-05-26       Impact factor: 3.264

2.  Deletion of the Gene Encoding the NMDA Receptor GluN1 Subunit in Schwann Cells Causes Ultrastructural Changes in Remak Bundles and Hypersensitivity in Pain Processing.

Authors:  Coralie Brifault; Haylie Romero; Alicia Van-Enoo; Don Pizzo; Pardis Azmoon; HyoJun Kwon; Chanond Nasamran; Steven L Gonias; Wendy M Campana
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

3.  Identification of Differentially Expressed Genes and Key Pathways in the Dorsal Root Ganglion After Chronic Compression.

Authors:  Zhanhui Du; Sen Yin; Xiuhui Song; Lechi Zhang; Shouwei Yue; Xiaofeng Jia; Yang Zhang
Journal:  Front Mol Neurosci       Date:  2020-05-05       Impact factor: 5.639

4.  Identification of the Hub Genes Related to Nerve Injury-Induced Neuropathic Pain.

Authors:  Kai Wang; Duan Yi; Zhuoyin Yu; Bin Zhu; Shuiqing Li; Xiaoguang Liu
Journal:  Front Neurosci       Date:  2020-05-20       Impact factor: 4.677

5.  Computational Functional Genomics-Based AmpliSeq™ Panel for Next-Generation Sequencing of Key Genes of Pain.

Authors:  Dario Kringel; Sebastian Malkusch; Eija Kalso; Jörn Lötsch
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

6.  Gene correlation network analysis to identify regulatory factors in sciatic nerve injury.

Authors:  Liuxun Li; Xiaokang Du; Haiqian Ling; Yuhang Li; Xuemin Wu; Anmin Jin; Meiling Yang
Journal:  J Orthop Surg Res       Date:  2021-10-18       Impact factor: 2.359

7.  Analysis of Potential Hub Genes for Neuropathic Pain Based on Differential Expression in Rat Models.

Authors:  Jie Bai; Bin Geng; Xingwen Wang; Shenghong Wang; Yayi Xia
Journal:  Pain Res Manag       Date:  2022-03-03       Impact factor: 3.037

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.